About
The search results appear to conflate several different people named Mina Kim; this profile resolves to the biotech executive associated with ACELYRIN. She became ACELYRIN's Chief Executive Officer and a board member on May 9, 2024, after serving as its Chief Legal and Administrative Officer. Earlier roles included Chief Legal Officer and Head of Corporate Development at Zymergen, Senior Vice President of Corporate Strategy and General Counsel at Atara Biotherapeutics, and General Counsel at Sunrun.
Areas of interest
biotechimmunologysynthetic biologycorporate strategycorporate developmentlegal and regulatorypublic company operationsrenewable energyaviation